Requirement for producer cell line for GMP viral vector packaging

A Contract Award Notice
by NHS BLOOD AND TRANSPLANT (NHSBT)

Source
Contracts Finder
Type
Framework (Products)
Duration
2 year
Value
£50K-£111K
Sector
HEALTH
Published
13 Apr 2022
Delivery
07 Apr 2022 to 05 Apr 2024
Deadline
03 Jun 2020 12:00

Concepts

Location

Geochart for 1 buyers and 1 suppliers

1 buyer

1 supplier

Description

NHSBT's Clinical Biotechnology Centre for the purpose of specifying the user requirement for HEK293-derived production cell line for the GMP-production of viral vectors and other recombinant proteins. The CBC has an MHRA licence for the manufacture of investigational medicinal gene therapy and recombinant protein products for use in clinical trials. In order to manufacture GMP-grade viral vectors and recombinant proteins for clinical trials, a GMP-qualified producer cell line is required.

Award Detail

1 Life Technologies (Paisley)
  • Value: £111,000

CPV Codes

  • 33141000 - Disposable non-chemical medical consumables and haematological consumables

Reference

Domains